Aktis Oncology Common Stock Price Patterns
| AKTS Stock | USD 17.95 0.19 1.07% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Aktis Oncology hype-based prediction, you can estimate the value of Aktis Oncology Common from the perspective of Aktis Oncology response to recently generated media hype and the effects of current headlines on its competitors.
Aktis Oncology Common Hype to Price Pattern
Investor biases related to Aktis Oncology's public news can be used to forecast risks associated with an investment in Aktis. The trend in average sentiment can be used to explain how an investor holding Aktis can time the market purely based on public headlines and social activities around Aktis Oncology Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Aktis Oncology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Aktis Oncology.
The fear of missing out, i.e., FOMO, can cause potential investors in Aktis Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Aktis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aktis Oncology after-hype prediction price | USD 18.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Aktis Oncology Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aktis Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aktis Oncology After-Hype Price Density Analysis
As far as predicting the price of Aktis Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aktis Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aktis Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Aktis Oncology Estimiated After-Hype Price Volatility
In the context of predicting Aktis Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aktis Oncology's historical news coverage. Aktis Oncology's after-hype downside and upside margins for the prediction period are 14.07 and 22.51, respectively. We have considered Aktis Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aktis Oncology is not too volatile at this time. Analysis and calculation of next after-hype price of Aktis Oncology Common is based on 3 months time horizon.
Aktis Oncology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Aktis Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aktis Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aktis Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.76 | 4.22 | 0.34 | 0.75 | 9 Events / Month | 2 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.95 | 18.29 | 1.89 |
|
Aktis Oncology Hype Timeline
Aktis Oncology Common is presently traded for 17.95. The entity has historical hype elasticity of 0.34, and average elasticity to hype of competition of 0.75. Aktis is anticipated to increase in value after the next headline, with the price projected to jump to 18.29 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 1.89%, whereas the daily expected return is presently at -0.76%. The volatility of related hype on Aktis Oncology is about 429.52%, with the expected price after the next announcement by competition of 18.70. The company reported the previous year's revenue of 1.49 M. Net Loss for the year was (43.98 M) with loss before overhead, payroll, taxes, and interest of (58 M). Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Aktis Oncology Basic Forecasting Models to cross-verify your projections.Aktis Oncology Related Hype Analysis
Having access to credible news sources related to Aktis Oncology's direct competition is more important than ever and may enhance your ability to predict Aktis Oncology's future price movements. Getting to know how Aktis Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aktis Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BESVF | BE Semiconductor Industries | 0.00 | 0 per month | 0.00 | 0.10 | 3.69 | (0.27) | 37.71 | |
| MX | MagnaChip Semiconductor | 0.03 | 8 per month | 2.17 | 0.10 | 5.10 | (3.73) | 18.85 | |
| THG | The Hanover Insurance | 0.45 | 8 per month | 0.00 | (0.08) | 1.71 | (2.03) | 5.99 | |
| GCTS | GCT Semiconductor Holding | (0.03) | 6 per month | 3.79 | (0.01) | 6.62 | (6.78) | 35.21 | |
| EXCH | Exchange Bankshares | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 17.10 | |
| NXPI | NXP Semiconductors NV | 7.41 | 10 per month | 1.75 | 0.11 | 5.55 | (3.09) | 14.37 | |
| AFSIP | AmTrust Financial Services | 0.00 | 0 per month | 2.28 | (0.01) | 5.24 | (5.62) | 15.19 | |
| NRSDY | Nordic Semiconductor ASA | 0.00 | 0 per month | 0.00 | 0.04 | 0.00 | (1.72) | 24.28 |
Aktis Oncology Additional Predictive Modules
Most predictive techniques to examine Aktis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aktis using various technical indicators. When you analyze Aktis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Aktis Oncology Predictive Indicators
The successful prediction of Aktis Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aktis Oncology Common, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aktis Oncology based on analysis of Aktis Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aktis Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aktis Oncology's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 16.07 | 15.98 | 18.38 | 20.97 | Net Debt To EBITDA | 0.48 | 0.5 | 0.57 | 0.54 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aktis Stock Analysis
When running Aktis Oncology's price analysis, check to measure Aktis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aktis Oncology is operating at the current time. Most of Aktis Oncology's value examination focuses on studying past and present price action to predict the probability of Aktis Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aktis Oncology's price. Additionally, you may evaluate how the addition of Aktis Oncology to your portfolios can decrease your overall portfolio volatility.